Compile Data Set for Download or QSAR
Report error Found 7 of ki for UniProtKB: P08648
TargetIntegrin alpha-5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM10484(US8846719, 301 | US11091471, Example RO-301 | US20...)
Affinity DataKi:  0.200nMAssay Description:Electrophysiological experiments were performed on days 3 to 5 after the micro-injection of mRNA. During the experiment the oocytes were constantly s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
Go to US Patent

TargetIntegrin alpha-5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM513334(US11091471, Example RE-B | US20240279218, Example ...)
Affinity DataKi:  0.400nMAssay Description:Electrophysiological experiments were performed on days 3 to 5 after the micro-injection of mRNA. During the experiment the oocytes were constantly s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
Go to US Patent

TargetIntegrin alpha-5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM133559(US8846719, 251 | US11091471, Example RO-251 | US20...)
Affinity DataKi:  1nMAssay Description:Electrophysiological experiments were performed on days 3 to 5 after the micro-injection of mRNA. During the experiment the oocytes were constantly s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
Go to US Patent

TargetIntegrin alpha-5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM133580(US8846719, 272 | US11091471, Example RO-272 | US20...)
Affinity DataKi:  1nMAssay Description:Electrophysiological experiments were performed on days 3 to 5 after the micro-injection of mRNA. During the experiment the oocytes were constantly s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
Go to US Patent

TargetIntegrin alpha-5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM513332(US11091471, Example RO-094 | US20240279218, Exampl...)
Affinity DataKi:  2.90nMAssay Description:Electrophysiological experiments were performed on days 3 to 5 after the micro-injection of mRNA. During the experiment the oocytes were constantly s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
Go to US Patent

TargetIntegrin alpha-5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM133472(US8846719, 159 | US11091471, Example RO-159 | US20...)
Affinity DataKi:  28nMAssay Description:Electrophysiological experiments were performed on days 3 to 5 after the micro-injection of mRNA. During the experiment the oocytes were constantly s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
Go to US Patent

TargetIntegrin alpha-5(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM513333(US11091471, Example RE-A | US20240279218, Example ...)
Affinity DataKi:  65nMAssay Description:Electrophysiological experiments were performed on days 3 to 5 after the micro-injection of mRNA. During the experiment the oocytes were constantly s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/30/2022
Entry Details
Go to US Patent